Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 52 min ago
Peer-reviewedCC BY-NC-ND 4.0JACC Case Reports

Hemodynamic Compromise Due to Semaglutide-Associated Abdominal Distension

5 affiliations
  1. 1Division of Critical Care Cardiology, Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA
  2. 2Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA
  3. 3Department of Emergency Medicine, Mayo Clinic, Rochester, Minnesota, USA
  4. 4Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, USA
  5. 5Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, Minnesota, USA

Abstract

Background: Glucagon-like peptide-1 (GLP-1) agonists are becoming widely used, but commonly cause gastrointestinal side effects that are often mild but can occasionally be significant.

Case Summary: A 35-year-old male patient with obesity and otherwise minimal medical history presented to the emergency department after a syncopal episode that occurred several days after restarting high-dose GLP-1 agonist therapy. Imaging showed massive gastric distension with significant inferior vena cava compression. He developed low-output shock requiring very high-dose vasoactive medications, which resolved after gastric decompression via emesis, nasogastric tube placement, and intravenous fluid resuscitation.

Discussion: This case represents a heretofore unseen side effect of glucagon-like peptide-1 receptor agonist administration, with initiation of maximum-dose semaglutide leading to dramatic gastric distension causing inferior vena cava compression and low-output shock.

Take-Home Messages: In patients with unexplained hypotension, shock, and/or syncope on glucagon-like peptide-1 agonist therapy, adverse medication effects should be considered as possible etiologies. This case emphasizes the importance of gradual dose escalation of glucagon-like peptide-1 agonists under provider guidance.

Related

  1. Complex Cardiac Tumor with Concomitant Pericardial Effusion and Hemodynamic Compromise in a Septuagenarian: Case Report of Anesthetic and Surgical Considerations
    Amir Zabida, Ascher Schmelczer, Ehud Karni +2
    Annals of Cardiac AnaesthesiaPeer-reviewedCC BY-NC-SA 4.0Full textCardiovascular medicinePMC
  2. A nurse-led standardized bedside gastric ultrasound monitoring protocol for abdominal distension management in critically ill patients receiving enteral nutrition: a pragmatic, exploratory randomized controlled trial.
    Panpan Han, Ruxin Jiang, Huiyi Zhang
    Frontiers in medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMCPMC
  3. Mechanical and Hemodynamic Effects of Balloon-Expandable and Self-Expanding Stents in a Saccular Abdominal Aortic Aneurysm Model: Fluid–Structure Interaction Analyses
    Masanori Murakami, Fei Jiang, Tatsuo Yamashita +1
    Annals of Vascular DiseasesPeer-reviewedCC BY 4.0Full textGeneral medicinePMC
  4. Comparison of intraoperative hemodynamic changes and recovery outcomes between non-menopausal and postmenopausal women undergoing total abdominal hysterectomy under general anesthesia.
    Banafsheh Mashak, Samira Abdollahi, Hananeh Habib +4
    BMC anesthesiologyPeer-reviewedCC BY-NC-NDFull textSurgery & anaesthesiaEurope PMCPMC
  5. Artificial intelligence-based surrogate modeling of hemodynamic indicators in abdominal aortic aneurysms using computational fluid dynamics
    MyeungHye Suh, Up Huh, Chiseung Lee
    PLOS OnePeer-reviewedCC BYFull textGeneral biologyGeometry & topologyPLOSEurope PMCPMC
BibTeX
@article{amdahl2026hemodynamic,
  title = {{Hemodynamic Compromise Due to Semaglutide-Associated Abdominal Distension}},
  author = {Matthew B. Amdahl and Vishwesh Bharadiya and Brian Obritsch and Obadi Obadi and Matthew Y. Wong and Matthew M. Rode and Jeahan Colletti and Gustavo A. Cortes Puentes and James Chen and Garima Dahiya},
  journal = {JACC Case Reports},
  year = {2026},
  month = sep,
  doi = {10.1016/j.jaccas.2026.110452},
  url = {https://doi.org/10.1016/j.jaccas.2026.110452},
  note = {CC BY-NC-ND 4.0},
}
RIS
TY  - JOUR
TI  - Hemodynamic Compromise Due to Semaglutide-Associated Abdominal Distension
AU  - Matthew B. Amdahl
AU  - Vishwesh Bharadiya
AU  - Brian Obritsch
AU  - Obadi Obadi
AU  - Matthew Y. Wong
AU  - Matthew M. Rode
AU  - Jeahan Colletti
AU  - Gustavo A. Cortes Puentes
AU  - James Chen
AU  - Garima Dahiya
PY  - 2026
DA  - 2026/09/30
JO  - JACC Case Reports
DO  - 10.1016/j.jaccas.2026.110452
UR  - https://doi.org/10.1016/j.jaccas.2026.110452
AB  - Background: Glucagon-like peptide-1 (GLP-1) agonists are becoming widely used, but commonly cause gastrointestinal side effects that are often mild but can occasionally be significant.  Case Summary: A 35-year-old male patient with obesity and otherwise minimal medical history presented to the emergency department after a syncopal episode that occurred several days after restarting high-dose GLP-1 agonist therapy. Imaging showed massive gastric distension with significant inferior vena cava compression. He developed low-output shock requiring very high-dose vasoactive medications, which resolved after gastric decompression via emesis, nasogastric tube placement, and intravenous fluid resuscitation.  Discussion: This case represents a heretofore unseen side effect of glucagon-like peptide-1 receptor agonist administration, with initiation of maximum-dose semaglutide leading to dramatic gastric distension causing inferior vena cava compression and low-output shock.  Take-Home Messages: In patients with unexplained hypotension, shock, and/or syncope on glucagon-like peptide-1 agonist therapy, adverse medication effects should be considered as possible etiologies. This case emphasizes the importance of gradual dose escalation of glucagon-like peptide-1 agonists under provider guidance.
SN  - 2666-0849
ER  -